Patients suffering from neurodegenerative diseases are treated by administering an effective amount of a gamma-nicotine compound.

This invention relates to a composition for use in the treatment of iodine deficiency diseases such as fibrocystic dysplasia of the breast, breast cancer, endometriosis and premenstrual syndrome. The composition may also be used for the prophylaxis of breast cancer. More particularly, this invention relates to a composition for the treatment of iodine deficiency diseases, the composition comprising a solution of elemental iodine (I.sub.2), which may also be referred to as metallic iodine or iodi...

Remedies for bone diseases comprising, as active ingredient, droloxifene or a salt thereof.

Patients suffering from neurodegenerative diseases are treated by administering an effective amount of certain anabasine compounds, certain unsaturated anabasine compounds or unsaturated nicotine compounds. Exemplary compounds are myosmine and anatabine.

The antibacterial substance baquiloprim (2,4-diamino-5-[8-dimethylamino-7-methyl-5-quinolylmethyl]pyrimidine) is shown to be active against protozoal infections, e.g. toxoplasmosis. Preferably the baquiloprim is administered together with a sulphonamide.

Patients suffering from neurodegenerative diseases are treated by administering an effective amount of a nicotine compound. Exemplary nicotine compounds are 5-fluoronicotine, 5-bromonicotine, 4.sup.1 -methylnicotine and 5-methylnicotine.

A method of diagnosing renal diseases by detecting fragments of albumin in human urine. The detection of the fragments is carried out by, for example, immunological methods or liquid chromatography techniques.

Patients suffering from neurodegenerative diseases are treated by administering an effective amount of a ferruginine compound or a anhydroecgonine compound.

Patients suffering from neurodegenerative diseases are treated by administering an effective amount of a phenylpyrrolidine compound.

There is disclosed an improved method for the treatment of viral skin diseases comprising the topical application of a chemical composition to the infected areas wherein the composition comprises captan and a surface active bactericide. In its preferred embodiment, the bactericide comprises benzethonium chloride. The composition is preferably incorporated into a topical vehicle to facilitate its application to the infected areas.